HST Global Inc. Capital Expenditures

Capital Expenditures of HSTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capital Expenditures growth rates and interactive chart. Capital expenditures, commonly known as Capex, are funds used by a company to acquire, upgrade, and maintain physical or intangible assets such as property, buildings, an industrial plant, technology, software or equipment. Capex is often used to undertake new projects or investments by the firm. A company must invest over its lifetime into productive assets to maintain its competitiveness and ensure its survival.


Highlights and Quick Summary

  • Capital Expenditures for the quarter ending December 30, 2011 was $0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Capital Expenditures decreased by NaN%
  • Twelve month Capital Expenditures ending December 30, 2011 was $0 (a NaN% decrease compared to previous quarter)
  • Twelve month trailing Capital Expenditures decreased by NaN% year-over-year
Trailing Capital Expenditures for the last four month:
30 Dec '11 30 Dec '10 29 Sep '10 29 Jun '10
$0 $0 $0 $0
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capital Expenditures of HST Global Inc.

Most recent Capital Expendituresof HSTC including historical data for past 10 years.

Interactive Chart of Capital Expenditures of HST Global Inc.

HST Global Inc. Capital Expenditures for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2011 $0.0
2010 $0.0 $0.0 $0.0 $0.0
2009 $0.0

Business Profile of HST Global Inc.

Sector: Medical
Industry: Drugs
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.